🔗 Permalink

Inventor profile of:

Ivan M. Borrello

City:

Baltimore, Maryland

Country:

United States

Published Applications:

Last publication date:

2024-09-26

Top Assignees for applications by Ivan M. Borrello

The entities that hold a legal rights for patent applications filed by inventor Borrello Ivan M.:

THE JOHNS HOPKINS UNIVERSITY 7 Baltimore, MD United States
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE 2 Baltimore, MD United States
MERIDIAN THERAPEUTICS, INC. 2 Draper, UT United States
The John Hopkins University 1 Baltimore, MD United States
WINDMIL THERAPEUTICS, INC. 1 Philadelphia, PA United States

Recent patent applications by Borrello Ivan M.

Ivan M. Borrello from Baltimore, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-09-26

US20240316103A1

Human necessities

COMPOSITIONS AND METHODS OF TREATING PLASMA CELL DISORDERS INCLUDING MULTIPLE MYELOMA WITH A VACCINE COMPOSITION AND MYELOMA-SPECIFIC CAR-T CELLS

#2 | 2024-07-18

US20240238342A1

Human necessities

A Vaccine Composition for Plasma Cell Disorders Including Multiple Myeloma and Methods to Induce Immunity Using Same

#3 | 2023-07-06

US20230210990A1

Human necessities

MARROW INFILTRATING LYMPHOCYTES (MILS) AS A SOURCE OF T-CELLS FOR CHIMERIC ANTIGEN RECEPTOR (CAR) THEREAPY

#4 | 2023-01-19

US20230016031A1

Human necessities

MARROW INFILTRATING LYMPHOCYTES (MILS) AS A SOURCE OF T-CELLS FOR CHIMERIC ANTIGEN RECEPTOR (CAR) THEREAPY

#5 | 2023-01-05

US20230000919A1

Human necessities

ACTIVATION OF MARROW INFILTRATING LYMPHOCYTES IN HYPOXIC ALTERNATING WITH NORMOXIC CONDITIONS

#6 | 2022-01-20

US20220016172A1

Human necessities

ACTIVATION OF MARROW INFILTRATING LYMPHOCYTES IN HYPOXIC ALTERNATING WITH NORMOXIC CONDITIONS

#7 | 2020-06-04

US20200171089A1

Human necessities

Use of Post-Transplant Cyclophosphamide Treated Allogenic Marrow Infiltrating Lymphocytes to Augment Anti-Tumor Immunity

#8 | 2019-11-21

US20190350982A1

Human necessities

Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions

#9 | 2019-10-03

US20190298768A1

Human necessities

Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions

#10 | 2018-07-19

US20180200367A1

Human necessities

Marrow infiltrating lymphocytes (MILs) as a source of T-cells for chimeric antigen receptor (CAR) therapy

#11 | 2018-07-05

US20180185434A1

Human necessities

IMMUNE CHECKPOINT CHIMERIC ANTIGEN RECEPTORS THERAPY

#12 | 2017-09-21

US20170266232A1

Human necessities

Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions

#13 | 2017-09-14

US20170258838A1

Human necessities

Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions

#14 | 2017-08-10

US20170224691A1

Human necessities

PDE INHIBITORS IN IMMUNOTHERAPY

#15 | 2016-11-17

US20160331781A1

Human necessities

Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions

#16 | 2015-11-12

US20150320798A1

Human necessities

Use of Post-Transplant Cyclophosphamide Treated Allogeneic Marrow Infiltrating Lymphocytes to Augment Anti-Tumor Immunity

#17 | 2014-09-11

US20140255433A1

Human necessities

PDE5 inhibitor compositions and methods for immunotherapy

#18 | 2010-10-28

US20100272760A1

Human necessities

Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine

#19 | 2009-03-19

US20090074796A1

Human necessities

Pde5 inhibitor compositions and methods for immunotherapy

#20 | 2006-10-19

US20060233770A1

Human necessities

Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine

InventorID:

903576 ⎘